![Leonard W. Seymour](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leonard W. Seymour
Präsident bei
British Society for Gene & Stem Cell Therapy
Profil
Leonard W.
Seymour is the founder of Hybrid BioSystems Ltd. which was founded in 2001.
He held the title of Director in 2010.
Currently, he is the Head-Clinical Pharmacology at the University of Oxford and the President of the British Society for Gene & Stem Cell Therapy.
Aktive Positionen von Leonard W. Seymour
| Unternehmen | Position | Beginn |
|---|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 04.12.2009 |
British Society for Gene & Stem Cell Therapy | Präsident | 04.12.2009 |
Ehemalige bekannte Positionen von Leonard W. Seymour
| Unternehmen | Position | Ende |
|---|---|---|
Hybrid BioSystems Ltd.
 Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Gründer | 15.12.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Commercial Services |
British Society for Gene & Stem Cell Therapy |
